[1] ANDERSON NM,SIMON MC.The tumor microenvironment［J］.Curr Biol,2020,30(16):R921-R925.
[2] PARK JH,PYUN WY,PARK HW.Cancer metabolism:phenotype,signaling and therapeutic targets［J］.Cells,2020,9(10):2308.
[3] CHEN XY,ZHANG J,ZHU JS.The role of m6A RNA methylation in human cancer［J］.Mol Cancer,2019,18(1):103.
[4] SUN T,WU R,MING L.The role of m6A RNA methylation in cancer［J］.Biomed Pharmacother,2019,112:108613.
[5] SONG P,TAYIER S,CAI Z,et al.RNA methylation in mammalian development and cancer［J］.Cell Biol Toxicol,2021,37(6):811-831.
[6] QIN Y,LI L,LUO E,et al.Role of m6A RNA methylation in cardiovascular disease (Review)［J］.Int J Mol Med,2020,46(6):1958-1972.
[7] ZHANG B,JIANG H,DONG Z,et al.The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases［J］.Genes Dis,2021,8(6):746-758.
[8] LAN Q,LIU PY,BELL JL,et al.The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis,drug sensitivity,and resistance［J］.Cancer Res,2021,81(13):3431-3440.
[9] ZHOU H,YIN K,ZHANG Y,et al.The RNA m6A writer METTL14 in cancers:Roles,structures,and applications［J］.Biochim Biophys Acta Rev Cancer,2021,1876(2):188609.
[10] WANG T,KONG S,TAO M,et al.The potential role of RNA N6-methyladenosine in cancer progression［J］.Mol Cancer,2020,19(1):88.
[11] YUE Y,LIU J,CUI X,et al.VIRMA mediates preferential m6A mRNA methylation in 3' UTR and near stop codon and associates with alternative polyadenylation［J］.Cell Discov,2018,4:10.
[12] BAWANKAR P,LENCE T,PAOLANTONI C,et al.Hakai is required for stabilization of core components of the m6A mRNA methylation machinery［J］.Nat Commun,2021,12(1):3778.
[13] CHELMICKI T,ROGER E,TEISSANDIER A,et al.m6A RNA methylation regulates the fate of endogenous retroviruses［J］.Nature,2021,591(7849):312-316.
[14] ZHANG M,BODI Z,MACKINNON K,et al.Two zinc finger proteins with functions in m6A writing interact with HAKAI［J］.Nat Commun,2022,13(1):1127.
[15] SU R,DONG L,LI Y,et al.METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis［J］.Nat Cell Biol,2022,24(2):205-216.
[16] ZUIDHOF HR,CALKHOVEN CF.Oncogenic and tumor-suppressive functions of the RNA demethylase FTO［J］.Cancer Res,2022,82(12):2201-2212.
[17] YOU Y,FU Y,HUANG M,et al.Recent advances of m6A demethylases inhibitors and their biological functions in human diseases［J］.Int J Mol Sci,2022,23(10):5815.
[18] AZZAM SK,ALSAFAR H,SAJINI AA.FTO m6A demethylase in obesity and cancer:implications and underlying molecular mechanisms［J］.Int J Mol Sci,2022,23(7):3800.
[19] QU J,YAN H,HOU Y,et al.RNA demethylase ALKBH5 in cancer:from mechanisms to therapeutic potential［J］.J Hematol Oncol,2022,15(1):8.
[20] CHANG H,YANG J,WANG Q,et al.Role of N6-methyladenosine modification in pathogenesis of ischemic stroke［J］.Expert Rev Mol Diagn,2022,22(3):295-303.
[21] WANG S,GAO S,ZENG Y,et al.N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer［J］.Gastroenterology,2022,162(4):1183-1196.
[22] XU Z,LV B,QIN Y,et al.Emerging roles and mechanism of m6A methylation in cardiometabolic diseases［J］.Cells,2022,11(7):1101.
[23] ZHAO Y,ZHAO H,ZHANG D,et al.YTHDF3 facilitates eIF2AK2 and eIF3A recruitment on mRNAs to regulate translational processes in oxaliplatin-resistant colorectal cancer［J］.ACS Chem Biol,2022,17(7):1778-1788.
[24] LAN Q,LIU PY,HAASE J,et al.The critical role of RNA m6A methylation in cancer［J］.Cancer Res,2019,79(7):1285-1292.
[25] ZACCARA S,JAFFREY SR.A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA［J］.Cell,2020,181(7):1582-1595.
[26] LI S,QI Y,YU J,et al.Nuclear aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4［J］.Signal Transduct Target Ther,2022,7(1):97.
[27] WIDAGDO J,ANGGONO V,WONG JJ.The multifaceted effects of YTHDC1-mediated nuclear m6A recognition［J］.Trends Genet,2022,38(4):325-332.
[28] MA C,LIAO S,ZHU Z.Crystal structure of human YTHDC2 YTH domain［J］.Biochem Biophys Res Commun,2019,518(4):678-684.
[29] TANG J,CHEN Z,WANG Q,et al.hnRNPA2B1 promotes colon cancer progression via the MAPK pathway［J］.Front Genet,2021,12:666451.
[30] LIU H,LI D,SUN L,et al.Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression［J］.Mol Cancer,2022,21(1):74.
[31] PENG WZ,ZHAO J,LIU X,et al.hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression［J］.Cancer Cell Int,2021,21(1):281.
[32] GAO LB,ZHU XL,SHI JX,et al.HnRNPA2B1 promotes the proliferation of breast cancer MCF-7 cells via the STAT3 pathway［J］.J Cell Biochem,2021,122(3-4):472-484.
[33] QUAN W,LI J,LIU L,et al.Influence of N6-methyladenosine modification gene HNRNPC on cell phenotype in Parkinson's disease［J］.Parkinsons Dis,2021,2021:9919129.
[34] ZHOU KI,SHI H,LYU R,et al.Regulation of co-transcriptional pre-mRNA splicing by m6A through the low-complexity protein hnRNPG［J］.Mol Cell,2019,76(1):70-81.
[35] SUN CY,CAO D,DU BB,et al.The role of insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer［J］.Int J Biol Sci,2022,18(7):2744-2758.
[36] DU QY,ZHU ZM,PEI DS.The biological function of IGF2BPs and their role in tumorigenesis［J］.Invest New Drugs,2021,39(6):1682-1693.
[37] LI Y,ZHAO L,LI XF.Hypoxia and the tumor microenvironment［J］.Technol Cancer Res Treat,2021,20:2091189104.
[38] DOWNS-CANNER SM,MEIER J,VINCENT BG,et al.B cell function in the tumor microenvironment［J］.Annu Rev Immunol,2022,40:169-193.
[39] YU W,LEI Q,YANG L,et al.Contradictory roles of lipid metabolism in immune response within the tumor microenvironment［J］.J Hematol Oncol,2021,14(1):187.
[40] ROMERO-LOPEZ M,TRINH AL,SOBRINO A,et al.Recapitulating the human tumor microenvironment:Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth［J］.Biomaterials,2017,116:118-129.
[41] BIFFI G,TUVESON DA.Diversity and biology of cancer-associated fibroblasts［J］.Physiol Rev,2021,101(1):147-176.
[42] CORN KC,WINDHAM MA,RAFAT M.Lipids in the tumor microenvironment:From cancer progression to treatment［J］.Prog Lipid Res,2020,80:101055.
[43] ROIFE D,SARCAR B,FLEMING JB.Stellate cells in the tumor microenvironment［J］.Adv Exp Med Biol,2020,1263:67-84.
[44] ZHAI Y,ZHENG L.m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma［J］.Sci Rep,2022,12(1):16358.
[45] WANG L,HUI H,AGRAWAL K,et al.m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy［J］.EMBO J,2020,39(20):e104514.
[46] SONG H,SONG J,CHENG M,et al.METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells［J］.Nat Commun,2021,12(1):5522.
[47] LI Y,SU R,DENG X,et al.FTO in cancer:functions,molecular mechanisms,and therapeutic implications［J］.Trends Cancer,2022,8(7):598-614.
[48] GU X,ZHANG Y,LI D,et al.N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation［J］.Cell Signal,2020,69:109553.
[49] MORAD G,HELMINK BA,SHARMA P,et al.Hallmarks of response,resistance,and toxicity to immune checkpoint blockade［J］.Cell,2021,184(21):5309-5337.
[50] TSURUTA N,TSUCHIHASHI K,OHMURA H,et al.RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells［J］.Biochem Biophys Res Commun,2020,530(1):235-239.
[51] DONG F,QIN X,WANG B,et al.ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment［J］.Cancer Res,2021,81(23):5876-5888.
[52] HAN D,LIU J,CHEN C,et al.Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells［J］.Nature,2019,566(7743):270-274.
[53] HU J,QIU D,YU A,et al.YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy［J］.Front Oncol,2021,11:607224.
[54] BAI X,WONG CC,PAN Y,et al.Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells［J］.J Immunother Cancer,2022,10(2):e003663.
[55] VAUPEL P,MULTHOFF G.Revisiting the Warburg effect:historical dogma versus current understanding［J］.J Physiol,2021,599(6):1745-1757.
[56] XUE L,LI J,LIN Y,et al.m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer［J］.J Cell Physiol,2021,236(4):2649-2658.
[57] LU S,HAN L,HU X,et al.N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect:implication in colorectal cancer［J］.J Hematol Oncol,2021,14(1):188.
[58] WANG Q,GUO X,LI L,et al.N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification［J］.Cell Death Dis,2020,11(10):911.
[59] YU H,ZHAO K,ZENG H,et al.N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability［J］.Biomed Pharmacother,2021,133:111075.
[60] YU H,YANG X,TANG J,et al.ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2alpha-mediated glycolysis［J］.Mol Ther Nucleic Acids,2021,23:27-41.
[61] YANG X,SHAO F,GUO D,et al.WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis［J］.Cell Death Dis,2021,12(5):462.
[62] BIAN X,LIU R,MENG Y,et al.Lipid metabolism and cancer［J］.J Exp Med,2021,218(1):e20201606.
[63] YANG Y,CAI J,YANG X,et al.Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma［J］.Mol Ther,2022,30(6):2342-2353.
[64] SUN D,ZHAO T,ZHANG Q,et al.Fat mass and obesity-associated protein regulates lipogenesis via m6A modification in fatty acid synthase mRNA［J］.Cell Biol Int,2021,45(2):334-344.
[65] GUO H,WANG B,XU K,et al.m6A reader HNRNPA2B1 promotes esophageal cancer progression via up-regulation of ACLY and ACC1［J］.Front Oncol,2020,10:553045.
[66] ENIAFE J,JIANG S.The functional roles of TCA cycle metabolites in cancer［J］.Oncogene,2021,40(19):3351-3363.
[67] XIAO Y,THAKKAR KN,ZHAO H,et al.The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor［J］.Proc Natl Acad Sci USA,2020,117(35):21441-21449.
[68] ZHU S,WANG JZ,CHEN D,et al.An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis［J］.Nat Commun,2020,11(1):1685.
[69] LI H,ZHANG Y,GUO Y,et al.ALKBH1 promotes lung cancer by regulating m6A RNA demethylation［J］.Biochem Pharmacol,2021,189:114284.
[70] COURTNEY KD,BEZWADA D,MASHIMO T,et al.Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo［J］.Cell Metab,2018,28(5):793-800.
[71] GREEN NH,GALVAN DL,BADAL SS,et al.MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma［J］.Oncogene,2019,38(34):6211-6225.
[72] ZHUANG C,ZHUANG C,LUO X,et al.N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis［J］.J Cell Mol Med,2019,23(3):2163-2173.
[73] LIU X,GONZALEZ G,DAI X,et al.Adenylate kinase 4 modulates the resistance of breast cancer cells to tamoxifen through an m6A-based epitranscriptomic mechanism［J］.Mol Ther,2020,28(12):2593-2604.
[74] XU W,XIE S,CHEN X,et al.Effects of quercetin on the efficacy of various chemotherapeutic drugs in cervical cancer cells［J］.Drug Des Devel Ther,2021,15:577-588.
[75] SUN K,DU Y,HOU Y,et al.Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling［J］.Theranostics,2021,11(12):5831-5846.
[76] DING N,YOU A,TIAN W,et al.Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation［J］.Int J Biol Sci,2020,16(14):2595-2611.
[77] CHEN WW,QI JW,HANG Y,et al.Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA［J］.Eur Rev Med Pharmacol Sci,2020,24(8):4263-4270.
[78] PAN X,HONG X,LI S,et al.METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner［J］.Exp Mol Med,2021,53(1):91-102.
[79] SHRIWAS O,PRIYADARSHINI M,SAMAL SK,et al.DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG［J］.Apoptosis,2020,25(3-4):233-246.